What is Zai Lab Limited (ZLAB)?
Zai Lab Limited is a biopharmaceutical company focused on the development and commercialization of innovative medicines primarily for oncology, autoimmune, and infectious diseases. The company engages in research and development activities to advance novel therapies that address unmet medical needs. Zai Lab collaborates with global pharmaceutical and biotechnology companies to in-license and develop promising drug candidates. Its portfolio includes both internally developed and partnered products, spanning various stages of clinical development. The company operates within the biotechnology and pharmaceutical industry, emphasizing precision medicine and targeted therapies. Zai Lab aims to bring advanced treatments to patients through clinical trials and regulatory approvals. Its business model combines research innovation with strategic partnerships to accelerate drug development and market access. The company contributes to the global healthcare landscape by focusing on therapies that improve patient outcomes.
Zai Lab Limited Stock Price Today: Live Overview
The price today is shaped by trading dynamics, as Zai Lab Limited trades at $18.84. The session range extends from $18.55 to $18.9, with a daily percentage change of -1.2169%.
FAQ: Zai Lab Limited (ZLAB)
What is the current price of ZLAB stock?
The current price stands at $18.84.
Does ZLAB pay dividends?
Zai Lab Limited pays dividends via cash distributions (if applicable).
Does ZLAB have a formal corporate presence or regional headquarters in the UAE?
Zai Lab Limited has a registered presence in the DIFC, Dubai, UAE.
What is ZLAB best known for?
Zai Lab Limited is most famous for its biopharmaceutical research and development.
What assets are typically shown together with ZLAB?
Commonly shown alongside ZLAB: Exelixis, 4D Molecular Therapeutics Inc, Immutep Ltd - ADR
Latest shares articles



